当前位置: X-MOL 学术Nat. Cancer › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Tracking early response to immunotherapy
Nature Cancer ( IF 22.7 ) Pub Date : 2020-02-10 , DOI: 10.1038/s43018-020-0032-8
Genevieve M Boland 1 , Keith T Flaherty 2
Affiliation  

Identifying indicators of response to immunotherapy is key for treatment decisions. Two studies now report that early changes in T cell repertoires and CD8+ memory effector cytotoxic T cells in peripheral blood correlate with response to immune-checkpoint inhibitors in metastatic melanoma and may serve as actionable biomarkers of immune activation.

中文翻译:

跟踪对免疫疗法的早期反应

确定对免疫治疗反应的指标是治疗决策的关键。现在有两项研究报告说,外周血中 T 细胞库和 CD8+ 记忆效应细胞毒性 T 细胞的早期变化与转移性黑色素瘤对免疫检查点抑制剂的反应相关,并可能作为免疫激活的可操作生物标志物。
更新日期:2020-02-10
down
wechat
bug